Your Sorted CME/CE Activities

Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*
Certified AMA Activity - Clinical Clips

Clinicians need to keep up with recent progress in low-risk myelodysplastic syndromes (MDS) to facilitate appropriate integration of newly approved and novel therapies. 

This educational Clinical Clip will highlight key updates in low-risk MDS based on data presented at the 63rd American Society of Hematology (ASH) Annual Meeting.

Review the video to claim AMA credit after completion of the brief Post-Test/Evaluation.
Rami Komrokji, MD
Rami Komrokji, MD
Section Head - Leukemia & MDS, Vice Chair Malignant Hematology
Moffitt Cancer Center
Professor of Oncologic Sciences
Morsani College of Medicine, University of South Florida






*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the 2021 American Society of Hematology Annual Meeting (ASH)
20
Supported by an independent educational grant from Bristol Myers Squibb

Launch Date: December 16, 2021
Release Date: December 16, 2021
Expiration Date: November 30, 2022

November 30, 2022
Mini Module
7286
ClinicalClips_WebBanner.ASH.Myelodysplastic(1150).gif
Hem-Onc